Conversation: 420 Investor & Abattis Bioceuticals (ATTBF)

Benzinga PotProfits

Conversation: 420 Investor & Abattis Bioceuticals (ATTBF)

By Cannabis Analyst — Author

Alan Brochstein (420 Investor) sits down with Abattis Bioceuticals (ATT) leadership for a candid discussion about the state of the company and its opportunities in the cannabis sector.

Abbatis is an Vancouver-based bioceutical firm.

Slides

Contact: Mike Withrow, CEO - mike.withrow@abattis.com

Posted to Benzinga PotProfits on Mar 12, 2014 — 3:03 PM

Check out what my VIP members get

Recent free content from Cannabis Analyst

Marketfy Has Evolved - We're Moving to a New Platform! — 3/06/24
420 Investor Weekly Review 12/23/22 — 12/26/22
420 Investor Weekly Review 12/16/22 — 12/16/22
420 Investor Weekly Review 12/09/22 — 12/09/22
420 Investor Weekly Review 12/02/22 — 12/02/22

You can also use Ctrl+Enter to post

Comments ({[comments.length]})

Sort By:

Loading Comments

No comments. Break the ice and be the first!

Error loading comments Click here to retry

No comments found matching this filter

{[comment.author.username]} {[comment.author.username]} — Marketfy Staff — Maven — Member

{[comment.date_posted|date_format]} ● {[comment.date_posted|date_ago]} ● Edited ● Edit Comment ● Delete Comment

Want to add a comment? Take me to the new comment box!

By jasrai1 — 1 year ago

By George_Cann — 1 year ago

See All Reviews →

Benzinga PotProfits